Purines and Pyrimidine Derivatives
Purines have a bicyclic structure, consisting of a six-membered ring fused to a five-membered ring, both containing nitrogen atoms in key positions. Purine derivatives, such as adenine and guanine, are essential for the formation of DNA and RNA. These compounds have therapeutic applications in cancer and viral disease treatments by inhibiting cell replication. Pyrimidines, on the other hand, have a monocyclic six-membered structure with two nitrogen atoms. Their derivatives, such as cytosine, thymine, and uracil, are also essential components of DNA and RNA and are used in chemotherapy and antiviral treatments.
At CymitQuimica, we offer purine and pyrimidine derivatives for research in molecular biology, genomics, and the development of innovative therapies.
Found 8897 products of "Purines and Pyrimidine Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Tenofovir Bis(L-alanine Isopropyl Ester) Amide
CAS:Controlled ProductFormula:C21H36N7O6PColor and Shape:NeatMolecular weight:513.53Oseltamivir Acid Methyl Ester Phosphate Salt
CAS:<p>Applications An impurity of the antiviral drug Oseltamivir (O700100). It is a COVID19-related research product.<br></p>Formula:C15H29N2O8PColor and Shape:NeatMolecular weight:396.375-Hydroxymethyl-N,N-dimethyltryptamine
CAS:Controlled Product<p>Applications Degradation product of Sumatriptan Succinate (S810000).<br>References Xu, X. et al.: J. Pharmaceut. Biomed. 367, 26 (2001)<br></p>Formula:C13H18N2OColor and Shape:WhiteMolecular weight:218.29Diethyl p-Toluenesulfonyloxymethylphosphonate
CAS:Controlled Product<p>Applications Diethyl p-Toluenesulfonyloxymethylphosphonate is an antiviral agent and a Tenofovir (T018500) intermediate. Tenofovir is an acyclic phosphonate nucleotide analogue and reverse transcriptase inhibitor used as an anti-HIV agent.<br>References Shaw, J.-P., et al.: Pharm. Res., 14, 1824 (1997), Wyles, D., et al.: Clin Infect. Dis., 40, 174 (2005), Peng, J., et al.: J. Clin. Pharmacol., 46, 265 (2006), Seminari, E., et al.: J. Antimicrob. Chemother., 60, 831 (2007),<br></p>Formula:C12H19O6PSColor and Shape:NeatMolecular weight:322.31Urea-d4
CAS:Controlled Product<p>Applications Labelled Urea. Physiological regulator of nitrogen excretion in mammals; synthesized in the liver as an end-product of protein catabolism and excreted in urine. Also occurs normally in skin. Emollient; diuretic.<br>References Demetriou, A., et al.: Science, 233, 1190 (1986), Aebischer, P., et al.: Nat. Med., 2, 696 (1996), Prakash, S., et al.: Biotechnol. Bioeng., 46, 621 (1995),<br></p>Formula:CD4N2OColor and Shape:NeatMolecular weight:64.08(S)-9-[2-(Hydroxypropyl] Adenine
CAS:<p>Applications (S)-9-[2-(Hydroxypropyl] Adenine is an inhibitor of adenosine deaminase. (S)-9-[2-(Hydroxypropyl] Adenine is used in the preparation of antiviral acyclic nucleoside thiophosphonates such as (S)-Tenofovir Disoproxil Fumarate (T018506).<br>References Roux, L. et al.: Eur. J. Med. Chem., 63, 869 (2013); Schaeffer, H. et al.: J. Med. Chem., 15, 456 (1972); Schaeffer, H. & Vince, R.: J. Med. Chem., 10, 689 (1967)<br></p>Formula:C8H11N5OColor and Shape:Off White SolidMolecular weight:193.206(R)- 3-[(1-Methyl-2-pyrrolidinyl)methyl]-1H-Indole
CAS:Controlled ProductFormula:C14H18N2Color and Shape:NeatMolecular weight:214.31[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]monophenylester
CAS:Controlled Product<p>Applications [[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]monophenylester is an antiviral agent and a Tenofovir (T018500) intermediate. Tenofovir is an acyclic phosphonate nucleotide analogue and reverse transcriptase inhibitor, used as an anti-HIV agent.<br>References Shaw, J.-P., et al.: Pharm. Res., 14, 1824 (1997); Wyles, D., et al.: Clin Infect. Dis., 40, 174 (2005); Peng, J., et al.: J. Clin. Pharmacol., 46, 265 (2006); Seminari, E., et al.: J. Antimicrob. Chemother., 60, 831 (2007);<br></p>Formula:C15H18N5O4PColor and Shape:NeatMolecular weight:363.315-Aminoimidazole-4-carboxamide-13C2,15N Hydrochloride Salt
CAS:Controlled Product<p>Stability Very Hygroscopic<br>Applications A labelled metabolite of Temozolomide.<br>References Jaeken, J., et al.: Lancet, 2, 1058 (1984), Baggott, J., et al.: Biochem. J., 236, 193 (1986), Baggott, J., et al.: Arch. Dermatol., 135, 813 (1999),<br></p>Formula:C2C2H615NN3O·HClColor and Shape:BrownMolecular weight:165.5561,11b-Dedihydrotetrabenazine
CAS:Controlled Product<p>Applications 1,11b-Dedihydrotetrabenazine is a product of photolytic degradation of Tetrabenazine (T284000) which is a dopamine depleting agent.<br>References Bourezg, Z., et al.: J. Pharmaceut. Biomed., 91, 138 (2014); Schwartz, et al.: Biochem. Pharmacol., 15, 645 (1966); Janovic, J., et al.: Ann. Neurol., 11, 41 (1982); Janovic, J., et al.: Neurology, 38, 391 (1988);<br></p>Formula:C19H25NO3Color and Shape:NeatMolecular weight:315.41(N,N-Dimethyl-1-butanamine) Zolmitriptan Dimer
CAS:Controlled Product<p>Impurity Zolmitriptan USP Related Compound F<br>Stability Hygroscopic<br>Applications (N,N-Dimethyl-1-butanamine) Zolmitriptan Dimer (Zolmitriptan USP Related Compound F) is an impurity from the synthesis of Zolmitriptan (Z639000). Zolmitriptan is a Serotonin 5HTID-receptor agonist.<br>References Glen, R.C., et al.: J. Med. Chem., 38, 3566 (1995), Seaber, E., et al.: Brit. J. Clin. Pharmacol., 41, 141 (1996), Tepper, S.J., et al.: Curr. Med. Res. Opin., 15, 254 (1999)<br></p>Formula:C38H53N7O4Purity:>90%Color and Shape:NeatMolecular weight:671.87Caffeine Citrate
CAS:<p>Applications Caffeine citrate (Cafcit) is a citrate salt of Caffeine, sometimes used in medical treatment, including short-term treatment of apnea of prematurity (lack of breathing in premature infants). Caffeine citrate functions in much the same capacity as does caffeine, but takes effect more quickly; its speed of dissociation is faster than that of Caffeine. Caffeine citrate is typically only used to treat severe migraines.<br>References Zubair, U.M., et al.: Anal. Profiles Drug Subs., 15, 71 (1986); Cherrah, Y., et al.: Biochem. Pharmacol., 37, 1311 (1988); Grillon, C., et al.: Clin. Neurophysiol., 114, 1557 (2003); Duangdao, D., et al.: Behav. Brain Res., 205, 1 (2009);<br></p>Formula:C8H10N4O2·C6H8O7Color and Shape:WhiteMolecular weight:386.311-Methyl-1,4-dihydronicotinamide
CAS:Controlled Product<p>Stability Light Sensitive, Temperature Sensitive<br>Applications 1-Methyl-1,4-dihydronicotinamide (cas# 17750-23-1) is a compound useful in organic synthesis.<br></p>Formula:C7H10N2OColor and Shape:NeatMolecular weight:138.17Sumatriptan N-Oxide
CAS:Controlled Product<p>Impurity Sumatriptan EP Impurity D<br>Stability Hygroscopic, Unstable in DMSO<br>Applications Sumatriptan N-Oxide (Sumatriptan EP Impurity D) is the degradation product of the antimigraine drug Sumatriptan (S810000).<br>References Xu, X. et al.: J. Pharmac. Biomed. Anal., 26, 367 (2001); Cheng, K.N. et al.: J. Pharmac. Biomed. Anal., 17, 399 (1998);<br></p>Formula:C14H21N3O3SColor and Shape:Light Beige To Light BrownMolecular weight:311.40nPOC-POC Tenofovir Fumarate(Mixture of Diastereomers)
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Tenofovir (T018500) impurity.<br></p>Formula:C19H30N5O10P·C4H4O4Color and Shape:White To Off-WhiteMolecular weight:635.514-Hydroxy-1,3-benzenedicarbonitrile
CAS:Controlled Product<p>Applications 4-Hydroxy-1,3-benzenedicarbonitrile is used in the preparation of febuxostat (F229000), a non-purine xanthine oxidase inhibitor used as a treatment for hyperuricaemia and chronic gout.<br>References Smith, C.J., et al.: Bioorg. Med. Chem. Lett., 20, 346 (2010); Cramp. S., et al.: BIoorg. Med. Chem. Lett., 20, 2516 (2010); Sato, T., et al.: Bioorg. Med. Chem. Lett., 19, 184 (2009);<br></p>Formula:C8H4N2OColor and Shape:NeatMolecular weight:144.13p-Chlorophenylcyanoguanidine
CAS:Controlled Product<p>Impurity Proguanil USP Related Compound E (1-(4-chlorophenyl)-3-cyanoguanidine)<br>Applications Halo-aryl substituted guanidine derivative used in the preparation of antimalarial agents. Proguanil USP Related Compound E (1-(4-chlorophenyl)-3-cyanoguanidine).<br>References Warner, V. et al.: J. Pharmac. Sci., 66, 418 (1977); Das, A. et al.: Ind. Drugs, 20, 19 (1980);<br></p>Formula:C8H7ClN4Color and Shape:NeatMolecular weight:194.62Febuxostat 67M-2
CAS:Controlled Product<p>Applications Febuxostat 67M-2 is a derivative compound of Febuxostat 67M-1 (F229005) which is an inhibitor of xanthine oxidase. It reduces uric acid production in the body and also used to reduce the risk of gout or kidney stone formation.<br>References Du, J., et al.: Handbook of Metabolic Pathways of Xenobiotics, 4, 1395 (2014)<br></p>Formula:C16H16N2O4SColor and Shape:NeatMolecular weight:332.371-(6-Amino-9H-purin-2-yl)-N-methyl-1H-pyrazole-4-carboxamide
CAS:Controlled ProductFormula:C10H10N8OColor and Shape:NeatMolecular weight:258.24cis (2,3)-Dihydro Tetrabenazine
CAS:Controlled Product<p>Applications A metabolite of Tetrabenazine in vivo, which is likely the active pharmacological agent. The cis isomer of Dihydrotetrabenazine is used for the treatment of hyperkinetic movement disorders.<br>References Kilbourn, M., et al.: Eur. J. Pharmacol., 278, 249 (1995), Perera, R., et al.: J. Med. Chem., 46, 2599 (2003), Mager, D., et al.: J. Pharm. Sci., 94, 2475 (2005), Zheng, G., et al.: Bioorg. Med. Chem., 16, 5018 (2006),<br></p>Formula:C19H29NO3Color and Shape:NeatMolecular weight:319.44
![(S)-9-[2-(Hydroxypropyl] Adenine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FH952690.webp&w=3840&q=75)
![(R)- 3-[(1-Methyl-2-pyrrolidinyl)methyl]-1H-Indole](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FM326810.webp&w=3840&q=75)
![[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]monophenylester](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FA628898.webp&w=3840&q=75)
